Magnera Earnings Call Transcripts
Fiscal Year 2026
-
Magnera, formed by the merger of Berry Global's HHS division and Glatfelter, has completed integration and is focused on innovation, operational optimization, and debt reduction. The company leads in nonwovens, targets $395 million EBITDA in 2026, and manages input costs through contract mechanisms.
-
Magnera, formed from a 2024 merger, is a global leader in specialty nonwovens with a balanced revenue mix and strong innovation focus. 2026 guidance targets EBITDA growth and debt reduction, with key growth in wipes, adult incontinence, and infrastructure. Management remains confident in long-term value creation.
-
The meeting covered director elections, auditor ratification, and executive compensation approval, with all proposals passing by majority vote. No shareholder questions were submitted, and final voting results will be filed with the SEC.
-
Q1 results met expectations with $792M in sales and $93M Adjusted EBITDA, as synergy realization and Project Core drove performance despite regional headwinds. 2026 guidance targets 9% Adjusted EBITDA growth, flat volumes, and $100M in free cash flow, with strong cash generation supporting debt reduction.
Fiscal Year 2025
-
A diversified nonwovens leader highlighted strong Q4 results, raised 2026 guidance, and detailed ongoing cost optimization and innovation efforts. Regional trends showed resilience in North America and growth in adult care and healthcare, while integration synergies and deleveraging remain key priorities.
-
Q4 and full-year results exceeded expectations with strong free cash flow and reduced leverage. 2026 guidance calls for 9% EBITDA growth, driven by synergies and Project CORE, despite a cautious macro outlook and flat volume expectations.
-
Third quarter sales reached $839 million with $91 million in adjusted EBITDA, supported by synergy capture and cost initiatives. Project Core is set to deliver $20 million in annual savings, while full-year EBITDA guidance is confirmed at $360–$380 million.
-
A global non-wovens leader detailed its integration progress, synergy targets, and growth outlook following a recent spin-off and merger. The company is optimizing operations, focusing on innovation, and expects most synergy benefits in 2026-2027 as utilization and margins improve.
-
Q2 2025 sales reached $824 million, with adjusted EBITDA at $89 million, as strong Americas and Asia results were offset by European energy inflation and South American competition. Fiscal 2025 EBITDA guidance was revised to $360–$380 million, with free cash flow guidance reaffirmed at $75–$95 million.
-
First quarter post-merger saw 2% revenue growth to $700 million and 8% higher Adjusted EBITDA, with strong synergy capture and deleveraging focus. Guidance targets 7% earnings growth and $75–$95 million free cash flow for 2025.